- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Oncogenic alterations in advanced NSCLC: a molecular super-highway ; volume:12 ; number:1 ; day:12 ; month:2 ; year:2024 ; pages:1-30 ; date:12.2024
Biomarker Research ; 12, Heft 1 (12.2.2024), 1-30, 12.2024
- Creator
-
Friedlaender, Alex
Perol, Maurice
Banna, Giuseppe Luigi
Parikh, Kaushal
Addeo, Alfredo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-024-00566-0
- URN
-
urn:nbn:de:101:1-2404220823332.468693281470
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Friedlaender, Alex
- Perol, Maurice
- Banna, Giuseppe Luigi
- Parikh, Kaushal
- Addeo, Alfredo
- SpringerLink (Online service)
Other Objects (12)
Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations : Invited short review
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients
Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations
Highway to Success—Developing Advanced Polymer Therapeutics
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells
Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC
Afatinib in advanced NSCLC: a profile of its use
Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis
Fully automated VMAT treatment planning for advanced-stage NSCLC patients
Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer
Correction to: Afatinib in advanced NSCLC: a profile of its use
Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations : Invited short review
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients
Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations
Highway to Success—Developing Advanced Polymer Therapeutics
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells
Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC
Afatinib in advanced NSCLC: a profile of its use
Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis
Fully automated VMAT treatment planning for advanced-stage NSCLC patients
Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer
Correction to: Afatinib in advanced NSCLC: a profile of its use
Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations : Invited short review
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients
Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations
Highway to Success—Developing Advanced Polymer Therapeutics
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells
Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC
Afatinib in advanced NSCLC: a profile of its use
Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis
Fully automated VMAT treatment planning for advanced-stage NSCLC patients
Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer